Duke-Margolis
@DukeMargolis
Followers
4K
Following
1K
Media
1K
Statuses
5K
Improving health, health equity, and the value of health care by developing and implementing evidence-based policy solutions locally, nationally, and globally.
Durham, NC and Washington, DC
Joined February 2016
There's only one week left to register! Don't miss this hybrid workshop from Duke-Margolis and @US_FDA as experts discuss the pathway to advance hepatitis C elimination across impacted populations. Join the conversation in person or participate virtually:
0
1
5
RT @FDA_Drug_Info: Join FDA’s Center for Drug Evaluation and Research and @DukeMargolis on January 31, 2024 for a joint public hybrid meeti….
0
5
0
RT @johnahartford: WEBINAR | REGISTER: @DukeMargolis is holding a webinar 12/5 on the significant gap that exists between demand & supply o….
0
2
0
Join Senior Research Director Rob Saunders for the Primary Care Transformation Summit on December 4-7 as he discusses The Imperative to Scale Home-Based Primary Care (HBPC) for Patients with Complex Care:
0
0
0
RT @Health_Affairs: In part two of their Forefront article series, @montysmith96, @WillBleser, Jonathan Gonzalez-Smith, Bruce Leff, + Rob S….
0
2
0
RT @Health_Affairs: In part 1 of their Forefront article series, @montysmith96, @WillBleser, Jonathan Gonzalez-Smith, Bruce Leff, + Robert….
0
1
0
RT @US_FDA: We announced our jointly sponsored virtual public meeting with @@DukeMargolis titled, “Advancing Drug Development for the Preve….
0
1
0
Join Core Faculty member @dave_ridley this Wednesday, November 29, and learn more about industry insights and business education in health care. The event will be held in person at the Duke in DC office from 6:00 - 8:00 PM ET. Learn more & register here:
0
1
2
An agenda for the webinar, Improving Regulatory Practices to Sustain Antibiotic Innovation, is now available. Join Duke-Margolis on December 12 to learn more about strategies to overcome the regulatory barriers surrounding antibiotic development:
0
0
0
Don't miss out on this conversation! Join Duke-Margolis on December 5 to discuss recommendations to advance hepatitis C elimination across impacted populations. Attend in person for more opportunities to network, or participate virtually:
0
0
0
A new event has been announced! Learn what the new and revised CMS Innovation Center models mean for patients and providers during this Duke-Margolis webinar on December 13. Learn more and register here:
0
0
0
Don't forget to register for this event! Duke-Margolis is hosting a webinar on December 5 to explore opportunities to improve access to home-based primary care in rural populations. Check out the agenda and register here:
0
0
1
Don't miss this upcoming webinar! Learn more about novel antibiotics and how the regulatory process impacts their development on December 12 as Duke-Margolis gathers experts to discuss challenges and opportunities to improve antibiotic innovation:
0
0
1
RT @johnahartford: On #NationalRuralHealthDay, we honor #rural healthcare workers nationwide. Thank you for serving rural communities. @Du….
0
1
0
A new hybrid workshop has been announced! Join Duke-Margolis and the FDA on January 31, 2024, to discuss the successes and challenges of integrating quality by design and risk-based monitoring into the design and conduct of clinical trials:
0
1
1
Chronic hepatitis C infection is a leading cause of liver cancer and transplantation in the United States, despite the availability of curative therapies. Join Duke-Margolis on December 5 to discuss ways to advance hepatitis C elimination:
0
0
1
RT @DukeDCID: TODAY: Discussing global health, service delivery & opportunities to address longstanding challenges in development w/ Profs.….
0
4
0
The demand for home-based primary care services has led to a significant care gap, particularly in rural populations. Join Duke-Margolis on December 5 to explore opportunities to increase access to home-based primary care in rural populations:
0
0
0
Rare diseases and conditions collectively impact an estimated 30 million people in the United States, and many treatment needs remain unmet. On December 14, explore opportunities to advance therapeutic development through patient community engagement:
0
0
1
It's your last chance to register! Tomorrow, discover new strategies for reducing transmission & maximizing population-level benefit during fall respiratory virus seasons. Join the conversation in person at the National Press Club or participate virtually:
0
0
0